Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
about
Recent advances in oral vaccine development: yeast-derived β-glucan particlesRecent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticlesMammalian gastrointestinal tract parameters modulating the integrity, surface properties, and absorption of food-relevant nanomaterialsIn vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in ratsNanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells.Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength.Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injuryStyrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery - dual uptake through enterocytes and M-cells.Past, present, and future technologies for oral delivery of therapeutic proteins.Strategies to improve oral drug bioavailability.Microparticles for oral delivery of vaccines.Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System.Approaches for enhancing oral bioavailability of peptides and proteinsDesign aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.Evidence of oral translocation of anionic G6.5 dendrimers in mice.Nanoparticle strategies for the oral delivery of insulin.Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.Advances in oral macromolecular drug delivery.Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis.Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice.Characterization and evaluation of stabilized particulate formulations as therapeutic oral vaccines for allergy.Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drugTransepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral deliveryLiposomal α-galactosylceramide is taken up by gut-associated lymphoid tissue and stimulates local and systemic immune responses.Ex-Vivo Force Spectroscopy of Intestinal Mucosa Reveals the Mechanical Properties of Mucus Blankets.Mucosal vaccine delivery: is M cell-targeted delivery effective in the mucosal lumen?Modulating the immune system through nanotechnology.Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine.Nano-selenium and its nanomedicine applications: a critical review.Impact of nanoparticle surface functionalization on the protein corona and cellular adhesion, uptake and transport
P2860
Q27001699-8104882A-B269-4719-B342-5D3AFC22D749Q27028129-37EA3790-0F06-427C-9371-26355980E9B3Q28087071-2C58C925-5399-4F06-BDEC-C3CDA4135E4CQ28387077-87C99CDA-522E-4993-B50D-1EE51BEAABF6Q30391507-6C5AFEEB-8875-44B8-9158-71B090EC4C0AQ33800662-A6293E16-1CD3-4ECC-A7C3-F98E65C71D98Q34025399-227BCEF1-714F-453D-8E4F-4304227E5C5CQ34088840-FBA95FFA-A9F2-4D3C-A6E6-62D4685F8E62Q35892628-EFB449F0-685E-4957-8819-3B6CF3F1B2A9Q36232650-E85D2661-C056-404F-BFC8-86EE14F96EACQ36316751-9F8FE5C5-36A7-43F7-86B4-A93975C384F5Q36316809-9569AF87-EC4F-4ED7-A833-3FF6B6368AACQ36787641-6E5706A5-CF22-4563-8385-C753F3D634D7Q36922557-15959979-ABBD-4321-AB58-AA820177F082Q37015849-78028484-E1E5-4467-8242-D28730C2B478Q37024051-2E199084-BAB1-4E24-9C67-8F94AFCADB4FQ37039026-CA6DA9A1-3795-4648-B675-2297F21AAB3CQ38076188-9EBBEA95-B9F9-465A-8A1C-0421700D8EB7Q38235506-8149C6E5-D233-4E7B-9BB6-D0985A0635B1Q38266101-D5C69DFD-C3DA-4792-8BEC-0641E426A52EQ38828923-2D35BB18-40D6-4AC6-AA0C-F99C8FBB001BQ39151148-4DDB42E7-00E4-495A-B3BB-847A56DD9B2CQ39478652-B03CBB46-D711-41D9-9ABA-1E696267468BQ39681409-4244FB56-75C5-44D8-80C1-DA06D1953CAAQ40066630-DD514690-E279-4BC9-9521-6463E8AF553DQ41260449-2282CE25-48AD-4C0B-BB4A-0128EA6217F9Q44681342-A5545B69-F07C-4619-9DC7-026855EDB306Q48630939-9BD2AC01-D45C-442F-B1D5-ED996FDD8709Q51157119-B0E30A17-9F69-49ED-A00B-C4E8949EC0B5Q52564739-CCC7BA12-A944-4189-93A5-9F55567503C2Q58737783-C69859BC-92B6-4F1C-B111-AB1EB4E07F03
P2860
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
@ast
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
@en
type
label
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
@ast
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
@en
prefLabel
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
@ast
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
@en
P2860
P356
P1476
Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery
@en
P2093
Gilles Ponchel
Monjed Shakweh
P2860
P304
P356
10.1517/17425247.1.1.141
P407
P50
P577
2004-11-01T00:00:00Z